Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income (Loss) per Common Share (Tables)

9 Months Ended

Aug. 31, 2013

The following table sets forth the calculation of basic and diluted net income (loss) per common share:


	Three Months Ended					Nine Months Ended
	August 31, 2013		August 31, 2012			August 31, 2013		August 31, 2012
Numerator:
Net Income (Loss)	$	194,434	($	547,097	)	$	194,782	($	5,454,090	)

Denominator:
Weighted-average shares outstanding-basic		10,774,892		11,166,496			10,900,750		11,325,280
Dilutive common shares issuable upon exercise of stock options		89,007		—			109,529		—

Weighted-average shares-diluted		10,863,899		11,166,496			11,010,279		11,325,280

Net loss per common share:
Basic	$	0.02	($	0.05	)	$	0.02	($	0.48	)

Diluted	$	0.02	($	0.05	)	$	0.02	($	0.48	)